Recent discussions on X about ASP Isotopes Inc. (ASPI) have been buzzing with interest following a significant insider sale by a company director, which has sparked varied reactions. Many users are dissecting the implications of the sale of 64,000 shares, with some expressing concern over the potential signal it sends about the company's future prospects. The conversation is lively, as participants debate whether this move reflects broader strategic shifts or merely personal financial decisions.
Additionally, there’s notable attention on ASPI’s operational milestones, particularly around isotope production and upcoming merger plans, which have fueled speculation about potential upside surprises. Posts on X highlight anticipation for clarity at investor events and key corporate developments expected in the near term. The mix of uncertainty and optimism keeps the dialogue engaging, as stakeholders weigh the balance of risks and opportunities.
Note: This discussion summary was generated from an AI condensation of post data.
ASP Isotopes Inc. Insider Trading Activity
ASP Isotopes Inc. insiders have traded $ASPI stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $ASPI stock by insiders over the last 6 months:
- PAUL ELLIOT MANN (Chief Executive Officer) has made 0 purchases and 5 sales selling 1,112,153 shares for an estimated $6,697,927.
- ROBERT AINSCOW (Chief Operating Officer) has made 0 purchases and 4 sales selling 208,438 shares for an estimated $1,193,291.
- DUNCAN MOORE sold 75,000 shares for an estimated $696,232
- MICHAEL GORLEY sold 64,000 shares for an estimated $624,236
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ASP Isotopes Inc. Hedge Fund Activity
We have seen 92 institutional investors add shares of ASP Isotopes Inc. stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. added 4,179,934 shares (+inf%) to their portfolio in Q2 2025, for an estimated $30,764,314
- ROVIDA ADVISORS INC. added 2,200,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $16,192,000
- ROVIDA INVESTMENT MANAGEMENT LTD added 1,850,000 shares (+528.6%) to their portfolio in Q2 2025, for an estimated $13,616,000
- BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. removed 1,672,731 shares (-46.0%) from their portfolio in Q2 2025, for an estimated $12,311,300
- DRIEHAUS CAPITAL MANAGEMENT LLC added 1,405,414 shares (+inf%) to their portfolio in Q2 2025, for an estimated $10,343,847
- EXCHANGE TRADED CONCEPTS, LLC added 1,303,414 shares (+inf%) to their portfolio in Q2 2025, for an estimated $9,593,127
- PHILADELPHIA FINANCIAL MANAGEMENT OF SAN FRANCISCO, LLC removed 837,851 shares (-23.9%) from their portfolio in Q2 2025, for an estimated $6,166,583
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ASP Isotopes Inc. Analyst Ratings
Wall Street analysts have issued reports on $ASPI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 05/21/2025
To track analyst ratings and price targets for ASP Isotopes Inc., check out Quiver Quantitative's $ASPI forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
